257 related articles for article (PubMed ID: 37711206)
21. Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies.
Chen KH; Wada M; Firor AE; Pinz KG; Jares A; Liu H; Salman H; Golightly M; Lan F; Jiang X; Ma Y
Oncotarget; 2016 Aug; 7(35):56219-56232. PubMed ID: 27494836
[TBL] [Abstract][Full Text] [Related]
22. Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?
Lunning MA; Horwitz S
Curr Treat Options Oncol; 2013 Jun; 14(2):212-23. PubMed ID: 23568456
[TBL] [Abstract][Full Text] [Related]
23. Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?
Casulo C; Horwitz S
Curr Oncol Rep; 2010 Nov; 12(6):374-82. PubMed ID: 20737300
[TBL] [Abstract][Full Text] [Related]
24. The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management.
Armitage JO
Am J Hematol; 2012 May; 87(5):511-9. PubMed ID: 22508369
[TBL] [Abstract][Full Text] [Related]
25. Treatment approaches in relapsed or refractory peripheral T-cell lymphomas.
Foster C; Kuruvilla J
F1000Res; 2020; 9():. PubMed ID: 32934797
[TBL] [Abstract][Full Text] [Related]
26. High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.
Nademanee A; Palmer JM; Popplewell L; Tsai NC; Delioukina M; Gaal K; Cai JL; Kogut N; Forman SJ
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1481-9. PubMed ID: 21338704
[TBL] [Abstract][Full Text] [Related]
27. Role of Haematopoietic Stem Cell Transplantation in Peripheral T-Cell Lymphoma.
Abeyakoon C; van der Weyden C; Harrop S; Khot A; Dickinson M; Yannakou CK; Prince HM
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114606
[TBL] [Abstract][Full Text] [Related]
28. Current Treatment Patterns and the Role of Upfront Autologous Stem Cell Transplantation in Patients with Peripheral T-Cell Lymphoma: A Korean Nationwide, Multicenter Prospective Registry Study (CISL 1404).
Cho H; Yoon DH; Shin DY; Koh Y; Yoon SS; Kim SJ; Do YR; Lee GW; Kwak JY; Park Y; Kim MK; Kang HJ; Yi JH; Yoo KH; Lee WS; Park BB; Jo JC; Eom HS; Kim HJ; Jeong SH; Won YW; Sohn BS; Kwon JH; Suh C; Kim WS
Cancer Res Treat; 2023 Apr; 55(2):684-692. PubMed ID: 36596727
[TBL] [Abstract][Full Text] [Related]
29. [Peripheral T-cell lymphoma: diagnosis and treatment].
Reimer P; Hentrich M
Dtsch Med Wochenschr; 2006 Mar; 131(13):685-90. PubMed ID: 16555177
[TBL] [Abstract][Full Text] [Related]
30. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380
[TBL] [Abstract][Full Text] [Related]
31. Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project.
Rüdiger T; Weisenburger DD; Anderson JR; Armitage JO; Diebold J; MacLennan KA; Nathwani BN; Ullrich F; Müller-Hermelink HK;
Ann Oncol; 2002 Jan; 13(1):140-9. PubMed ID: 11863096
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Revised European-American Lymphoma classification confirms the clinical relevance of immunophenotype in 560 cases of aggressive non-Hodgkin's lymphoma.
Melnyk A; Rodriguez A; Pugh WC; Cabannillas F
Blood; 1997 Jun; 89(12):4514-20. PubMed ID: 9192775
[TBL] [Abstract][Full Text] [Related]
33. Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas.
Satou A; Takahara T; Tsuzuki T
Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010351
[TBL] [Abstract][Full Text] [Related]
34. Current treatment of peripheral T-cell lymphoma.
Horwitz SM; Coiffier B; Hsi ED; Pro B
Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
[TBL] [Abstract][Full Text] [Related]
35. Current state of art for transplantation paradigms in peripheral T-cell lymphomas.
Perrone G; Farina L; Corradini P
Expert Rev Hematol; 2013 Aug; 6(4):465-74. PubMed ID: 23991932
[TBL] [Abstract][Full Text] [Related]
36. [Clinical analysis of 25 patients with aggressive peripheral T-cell lymphoma in advanced stage treated with autologous stem cell transplantation].
Zou D; Huang W; Liu H; Fu M; Li Z; Sui W; Qi J; Zhao Y; Ru K; Han M; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):455-9. PubMed ID: 26134007
[TBL] [Abstract][Full Text] [Related]
37. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen.
Smith SD; Bolwell BJ; Rybicki LA; Brown S; Dean R; Kalaycio M; Sobecks R; Andresen S; Hsi ED; Pohlman B; Sweetenham JW
Bone Marrow Transplant; 2007 Aug; 40(3):239-43. PubMed ID: 17530000
[TBL] [Abstract][Full Text] [Related]
38. Increased incidence of adult T cell leukemia-lymphoma and peripheral T cell lymphoma-not otherwise specified with limited improvement in overall survival: a retrospective analysis using data from the population-based Osaka Cancer Registry.
Fuji S; Kida S; Nakata K; Morishima T; Miyashiro I; Ishikawa J
Ann Hematol; 2021 Jan; 100(1):157-165. PubMed ID: 33089366
[TBL] [Abstract][Full Text] [Related]
39. Bone Marrow Transplantation for Peripheral T-Cell Non-Hodgkins' Lymphoma in First Remission.
Sharma M; Pro B
Curr Treat Options Oncol; 2015 Jul; 16(7):34. PubMed ID: 26076798
[TBL] [Abstract][Full Text] [Related]
40. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
